Skip to main navigation Skip to search Skip to main content

Trefoil factor 3 (TFF3): A promising indicator for diagnosing thyroid follicular carcinoma

Research output: Contribution to journal › Review article › peer-review

Abstract

Since the introduction of fine needle aspiration biopsy (FNAB) in the 1970's, a preoperative diagnostic technique for thyroid follicular carcinoma has long been awaited. Many markers that distinguish follicular carcinomas from adenomas have been reported; however, most of them have not been confirmed to be beneficial for clinical use. Trefoil factor 3 (TFF3) is a relatively new family of peptides that bears the three-loop trefoil domain. Several groups have reported that the suppression of TFF3 mRNA expression is related to malignant characteristics of thyroid follicular cell- derived tumors and the expression level of TFF3 mRNA is the most promising indicator for diagnosing follicular carcinoma. Development of 7F.F.3-based diagnostic methods is now ongoing and it may not be long before thyroid follicular carcinoma can be diagnosed preoperatively using an aspirated sample from the tumor.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
Journalendocrine journal
Volume56
Issue number1
DOIs
Publication statusPublished - 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Trefoil factor 3 (TFF3): A promising indicator for diagnosing thyroid follicular carcinoma'. Together they form a unique fingerprint.

Cite this